CAS No. |
119386-39-9 |
|---|---|
中文名称 |
(S)-2,6-二氨基-N-[(2S,5S,8S,11S,14S,17S,20S,23S)-1,27-二氨基-11,20-双(3-胍基丙基)-5-[(R)-1-羟基乙基]-2-(羟甲基)-8,14,17-三甲基-1,4,7,10,13,16,19,22-八氧代-3,6,9,12,15,18,21-七氮杂庚acosan-23-基]己酰胺 |
英文名称 |
(S)-2,6-Diamino-N-((2S,5S,8S,11S,14S,17S,20S,23S)-1,27-diamino-11,20-bis(3-guanidinopropyl)-5-((R)-1-hydroxyethyl)-2-(hydroxymethyl)-8,14,17-trimethyl-1,4,7,10,13,16,19,22-octaoxo-3,6,9,12,15,18,21-heptaazaheptacosan-23-yl)hexanamide |
别名 |
MYOSIN LIGHT CHAIN KINASE (11-19) AMIDE;MYOSIN KINASE INHIBITING PEPTIDE;myosin light chain kinase fragment 11-19 amide;KKRAARATS-NH2;LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-AMIDE;LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2;H-LYS-LYS-ARG-ALA-ALA-ARG-ALA-THR-SER-NH2;L-Serinamide, L-lysyl-L-lysyl-L-arginyl-L-alanyl-L-alanyl-L-arginyl-L-alanyl-L-threonyl- |
标准英文名 |
(S)-2,6-diamino-N-((2S,5S,8S,11S,14S,17S,20S,23S)-1,27-diamino-11,20-bis(3-guanidinopropyl)-5-((R)-1-hydroxyethyl)-2-(hydroxymethyl)-8,14,17-trimethyl-1,4,7,10,13,16,19,22-octaoxo-3,6,9,12,15,18,21-heptaazaheptacosan-23-yl)hexanamide |
MDL No. |
MFCD00076722 |
分子式 |
C40H78N18O11 |
分子量 |
987.18 |
精确分子量 |
986.61 |
SMILES |
C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O |
标准SMILES |
C[C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(N)=O |
用途 |
Inhibits hypotonicity-induced Ca²⁺ influx into cells; used in the study of human cervical cancer. |
InChIKey |
FDCBNCDCLDMQDU-BRXOZAAOSA-N |
|
|
评论 |
|---|